The market for cholesterol testing on the global level has been rapidly growing thanks to the increasing popularity and understanding of that factor affecting cardiovascular
health. Cholesterol tests are vital since they help in understanding the probability of heart disease, stroke, and other disorders, including dementia.
These illnesses become far more common as well as cardiovascular diseases along with population aging rates and therefore, they indicate extremely high and constantly growing demand for the offered range of cholesterol testing products and services.
Biosensors and point-of-care testing devices are some recent technologies that have brought changes in test accuracy and patient convenience, which is driving the market. Thus, the growing emphasis on cardiovascular diseases by governments and a boost in healthcare expenditure is also helping the cholesterol testing market expand.
North America is still the largest market for testing services, followed by Europe and Asia-Pacific due to the higher expenditure on health care, easy availability of testing services, and growing health consciousness among people.
Cholesterol Testing Market Demand has increased due to rising awareness about heart disease and stroke worldwide. With greater focus on preventive healthcare comes an increase in cholesterol testing both medical settings and home-use devices; more consumers are monitoring their levels regularly which drives growth within this market.
Innovations in point-of-care testing and home cholesterol monitoring devices are providing new opportunities for individuals. These innovations make it simpler for individuals to track their cholesterol levels without visiting a clinic, providing early detection of potential heart disease risks. Their accessibility is fueling global demand.
Increased rates of cardiovascular diseases and an aging population have spurred demand for regular cholesterol testing, with government bodies and health organizations advocating regular screening among high risk populations in order to combat heart disease and stroke, thereby further driving market expansion.
The market is also experiencing advances in non-invasive cholesterol testing technologies, such as wearable devices and advanced sensors, that offer greater accuracy, convenience, and comfort to users - creating significant opportunities both in developed and emerging markets. With continuous research and innovation taking place within this space, cholesterol testing stands to expand exponentially over the coming years.
As per WHO High cholesterol levels increase the risk of cardiovascular disease and stroke significantly, accounting for one third of global ischemic heart disease cases and estimated to have caused approximately 2.6 million deaths (4.5 percent) and 29.7 million disability adjusted life years (DALYs), or 2 percent of total DALYs worldwide. High cholesterol represents a serious public health threat both developed and developing nations alike.
The US Cholesterol Testing Market
The US Cholesterol Testing market is projected to be valued at
USD 76.9 billion in 2033 from the base value of
USD 35.9 billion in 2024 at a
CAGR of 8.8%. The trends and developments affecting the cholesterol testing market in the US include the following, with the first as the most significant; Shift towards point-of-care testing devices with quick and accurate level assessment of cholesterol.
Thus, a shift towards faster and easier screening mechanisms is observed, encouraged by the development of novel methods for cholesterol management in clinics and at home as well as advancements in biosensors and digital strips to boost cholesterol detection.
Market analysis indicates that people are buying cholesterol test kits at home, basically proving the idea that people are now opting for home-based health diagnoses. With the increasing concerns of high cholesterol levels coupled with other cardiovascular complications, more and more frequent screening of cholesterol levels is being conducted on the different populations in the US.
Recent processes consist of associations and collaborations with healthcare and diagnostic organizations to grow the possibility of getting cholesterol testing services, as well as testing products in the market that led to better user experiences and effectiveness.
Key Takeaways
- Market Size: The Global Cholesterol Testing Market size is estimated to have a value of USD 109.8 billion in 2024 and is expected to reach USD 247.5 billion by the end of 2033.
- The US Market Size: The US Cholesterol Testing market is projected to be valued at USD 35.9 billion in 2024. It is expected to witness subsequent growth in the upcoming period as it holds USD 76.9 billion in 2033 at a CAGR of 8.8%.
- By Product Segment Analysis: Test strips are now projected to dominate the global cholesterol testing market as they hold 37.1% of the market share in 2024.
- By Test Type Segment: High-density lipoprotein cholesterol tests are anticipated to capture a 33.2% market share in 2024.
- Regional Analysis: North America is expected to have the largest market share in the Global Cholesterol Testing Market with a share of about 38.9% in 2024.
- Global Growth Rate: The market is growing at a CAGR of 8.8 percent over the forecasted period.
Use Cases
- Routine Health Check-ups: Cholesterol tests are a necessary component of routine health check-ups for monitoring and maintenance of cholesterol levels to prevent cardiovascular diseases.
- Cardiovascular Risk Assessment: Cholesterol testing plays a very important role in assessing an individual for risk from heart disease or stroke and providing early interventions and treatment.
- Monitoring Treatment Efficacy: Regular cholesterol tests will allow patients who are being treated for high levels of cholesterol to assess the effectiveness of their medications and lifestyle changes.
- Home Health Monitoring: Home cholesterol test kits make it easy for someone to monitor the state of their cholesterol level, hence living a life of health alertness and being able to seek medical consultations.
Market Dynamic
Trends
Increasing Utilization of Telehealth for Cholesterol Management
Telehealth services are increasingly integrated with cholesterol testing, in which patients are able to monitor their levels remotely and receive expert guidance on what this means. The trend is really out of the growing acceptance of telemedicine, especially post-pandemic, and continuous management of cholesterol levels without frequent clinic visits.
Shift Towards Preventive Healthcare
There is a significant shift in the trend in healthcare, which is changing towards preventive healthcare, with much emphasis on the identification and management of people with high levels of cholesterol at an early stage.
Much aid to this trend has come from various health awareness campaigns and multiple initiatives aimed at educating the general public about the importance of screening once in a while for the prevention of cardiovascular diseases due to high cholesterol levels.
Growth Drivers
Technological Advancements in Testing Devices
The continuous innovations in cholesterol testing devices have resulted in advanced biosensors and portable point-of-care devices, which add functionalities to devices related to cholesterol testing for better accuracy, convenience, and accessibility. Such constant evolution developed for these techniques is an important factor forming the future expansion of the cholesterol test market through catering to dynamic healthcare providers' and patients' needs.
Government Initiatives and Health Programs
Governments and health organizations, across the globe, have initiated programs to fight the rising cases of cardiovascular diseases that include providing subsidies on testing cholesterols, public health campaigns, and encouraging routine health check-ups; these increase manifold the demand for Cholesterol Testing Products and Services.
Growth Opportunities
Expansion into Emerging Markets
Emerging markets in the regions of Asia-Pacific, Latin America, and Africa are propelling growth due to increased awareness regarding healthcare, the development of better infrastructure of healthcare facilities, and rising disposable incomes. Corporations are increasing their efforts in these markets to increase their geographical presence and fulfill many needs of the cholesterol testing market.
Innovative Home Testing Solutions Development
Increasingly, there is a preference toward home health care and self-monitoring, opening up opportunities for innovative developments of home cholesterol test kits. These kits bring convenience, privacy, and regular monitoring of the levels of cholesterol, hence their wide adoption among health-conscious people.
Restraints
Economic Barriers in Low-Income Regions
Advanced cholesterol testing devices and services are expensive. This becomes a big obstacle in low-income regions. The high cost hence reduces access to regular cholesterol screening, limiting the growth prospect for the market and demanding low-cost, affordable test solutions.
Variability in Test Accuracy
Variability in the accuracy of different methods of cholesterol testing could mismanage the levels of cholesterol by impacting the reliability of test results. Ensuring that standardization and that the quality of testing devices is guaranteed is very critical in dealing with this restraint to retain trust in cholesterol testing products.
Research Scope and Analysis
By Product Type
Test strips are now projected to dominate the global cholesterol testing market as they hold 37.1% of the market share in 2024. This dominance is because of their affordability, simplicity, and wide availability. Indeed, single-use testing strips are very popular when it comes to home cholesterol monitoring instruments because they are an indispensable and user-friendly way for an individual or user to know their cholesterol levels without having to get professional help.
Multi-use and
digital testing strips are gaining popularity because they hold better accuracy in their readings and are user-friendly. Its simplicity and ease of portability increase its usage in both home care and clinics. Besides, test strips require minimal training, which increases their applicability among all categories of people.
The overall low cost of test strips compared to other testing methods continuously gives the product dominance in the market because it offers an inexpensive way of conducting regular cholesterol tests. It is estimated that the demand for test strips and other accurate and reliable cholesterol testing merchandise the world over will continue to skyrocket against backdrops of healthcare systems increasingly focusing on preventive care and early diagnosis.
By Test Type
High-density lipoprotein cholesterol tests are anticipated to capture 33.2% of the market share in 2024 of the cholesterol testing market due to their principal role in measuring cardiovascular health. High-density lipoprotein cholesterol is commonly known as "good" cholesterol because of its main function in carrying this sort of fat away from the arteries back to the liver, from where it is then processed and cleared from the body. Elevated levels of HDL cholesterol are related to a low risk for heart disease and stroke; thus, HDL testing assumes a very important place in the management of cardiovascular risks.
Due to the increase in cardiovascular diseases all over the world, the demand for testing HDL cholesterol has also increased. Among the primary causes of death, heart-related illness is very common, and health professionals are moving towards enforcing periodic checks of HDL levels to identify the risks and decrease them at an early stage. Direct HDL tests and homogeneous HDL tests are in wide demand for the reason of their accuracy and reliability in measuring the levels of HDL cholesterol in indicating a person's profile of lipids.
Besides, advances in testing technologies and improvements in HDL cholesterol tests have made the procedure more efficient and accessible. Improvements in biosensors and point-of-care devices render HDL testing more convenient, faster, and easier for use in routine screenings either in clinical or home settings. Increased health awareness and preventive healthcare trends also contribute to the dominance of HDL tests, since people wish to take care of their cholesterol levels.
By Technology
Biosensors dominate the market for cholesterol testing in the aspect of high sensitivity and specificity with the results coming within a few minutes. Electrochemical-based biosensors have found wide acceptance for the testing of cholesterol due to their high accuracy and reliability in measuring the level of cholesterol inside the
blood.
These biosensors are used to detect biochemical reactions involved in the reaction of cholesterol with some specific enzymes so that readings can be obtained. Optical biosensors are also utilized to detect and measure cholesterol levels using optical means.
The accessibility and convenience of cholesterol testing will be much easier and more user-friendly with these two technological advances, which might be very important for their winning the market stake. Besides, they have been incorporated into point-of-care testing devices and home test kits, further enhancing convenience and usability.
The constant innovation in biosensor design and functionality has encouraged the use of such devices within both clinical and non-clinical settings, steadily cementing their position as market possible leaders for cholesterol testing.
By End User
Hospitals dominate the cholesterol testing market due to their comprehensive diagnostic capabilities and access to advanced testing technologies. These services offer comprehensive cholesterol testing solutions, from total cholesterol, HDL/LDL ratio testing and triglyceride profiles to accurately and comprehensive assessments of an individual patient's cholesterol levels. Hospitals employ skilled healthcare professionals that ensure proper administration and interpretation of these tests for effective cholesterol management and treatment planning.
Hospitals offer several advantages when it comes to cholesterol testing: an established infrastructure allows them to quickly conduct high-volume cholesterol testing while offering quick turnaround times; plus they often serve as referral centers for complex cases requiring testing - further reinforcing their role as cholesterol screening centers.
Hospitals' focus on preventive healthcare and early diagnosis has driven demand for routine cholesterol screening and monitoring services; hospitals therefore hold an impressive market share in this market and continue to deliver essential services to large patient populations.
The preventive healthcare and early diagnosis agendas of the hospitals act as drivers for routine cholesterol screening and monitoring. Thus, hospitals continue to hold a significant market share of the cholesterol testing market by providing many necessary services to a large patient population.
The Global Cholesterol Testing Market Report is segmented on the basis of the following:
By Product Type
- Test Strips
- Single-Use Test Strips
- Multi-Use Test Strips
- Digital Test Strips
- Test Kits
- Home Test Kits
- Professional Test Kits
- Point-of-Care Test Kits
- Laboratory Test Kits
- Test Meters
- Other Product Types
By Test Type
- High-density lipoprotein (HDL) Cholesterol
- Direct HDL Tests
- Homogeneous HDL Tests
- Low-density lipoprotein (LDL) Cholesterol
- Direct LDL Tests
- Homogeneous LDL Tests
- Total Cholesterol Test
- Enzymatic Total Cholesterol Tests
- Chemical Total Cholesterol Tests
- Triglycerides/VLDL Cholesterol Test
- Direct Triglycerides Tests
- VLDL Calculated Tests
- Other Test Types
By Technology
- Biosensors
- Electrochemical Biosensors
- Optical Biosensors
- Spectrometry
- Mass Spectrometry
- UV-Vis Spectrometry
- Chromatography
- Gas Chromatography
- Liquid Chromatography
By End User
- Hospitals
- Diagnostic Centers
- Others
Regional Analysis
North America is expected to dominate this market as it
holds 38.9% of the revenue share in the global cholesterol testing market in 2024, due to the fact that the prevalence rate of cardiovascular diseases in this region is one of the highest in the world, the advanced healthcare infrastructure, and various government initiatives to increase routine monitoring.
The presence of major market players, including Abbott Laboratories and Quest Diagnostics, and continuous technological advancements of cholesterol testing devices also support market growth.
The three key driving forces leading to the rise of cholesterol testing are growing health consciousness, a rapidly aging population, and favorable regulatory frameworks in Europe. Leading companies within the region that offer advanced testing products and testing services are Roche Diagnostics and Siemens Healthineers.
The launch of innovative testing technologies and the introduction of key players in the market, as well as increasing research and development activities in the region, led to market growth. It is the government initiatives aligned with a reduction in burden of the cardiovascular disease and raising awareness toward cholesterol management responsible for driving the market.
Also, with the aging population in North America, which is mostly prone to health problems caused by high cholesterol levels, there is a need to test cholesterol levels regularly. Besides, high spending on healthcare in the region and a preventive care focus are supporting the dominance in the global cholesterol testing market in North America.
By Region
North America
Europe
- Germany
- The U.K.
- France
- Italy
- Russia
- Spain
- Benelux
- Nordic
- Rest of Europe
Asia-Pacific
- China
- Japan
- South Korea
- India
- ANZ
- ASEAN
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of Latin America
Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Egypt
- Rest of MEA
Competitive Landscape
The global cholesterol testing market envisions a highly competitive market environment with various major players surging innovation and market growth. Major players include Abbott Laboratories, Roche Diagnostics, and Siemens Healthineers, which offer a wide range of products and services for testing for cholesterol. These market leader firms are spending on research and development to bring new testing technology into the market, most often which makes cholesterol tests more accurate and comfortable.
Furthermore, the current big contribution is from emerging players and start-up companies developing new home-testing kits and point-of-care devices. A number of strategic collaborations or tie-ups between diagnostic companies with healthcare providers are quite common. Many have an expanded market reach with their enhanced product offering.
Besides, market players look at geographical market expansion and a strengthening of their distribution network to increase greater market share. There is a consistent technological induction, product launches, and better accessibility and affordability of cholesterol testing solutions, which strengthen this competitive landscape.
Some of the prominent players in the Global Cholesterol Testing Market are:
- Abbott Laboratories
- Sigma-Aldrich Corp.
- Beckman Coulter Inc.
- Bio-Rad Laboratories Inc.
- Boston Heart Diagnostics Corporation
- Eurofins Scientific
- F. Hoffmann-La Roche Ltd.
- AccuTech LLC
- Akers Biosciences Inc.
- Home Access Health Corporation
- Laboratory Corporation of America Holdings
- PTS Diagnostics
- Other Key Players
Recent Developments
- July 2024: Abbott Laboratories launched a new digital cholesterol test strip, enhancing user convenience and accuracy in home cholesterol monitoring. This product is designed to integrate with mobile health apps, allowing users to track their cholesterol levels over time and share data with healthcare providers for better management.
- June 2024: Roche Diagnostics introduced an advanced point-of-care cholesterol testing device that offers rapid and precise cholesterol level assessments. This device is equipped with the latest biosensor technology, providing real-time results that can be immediately used for clinical decision-making.
- May 2024: Siemens Healthineers announced a strategic partnership with Ascension Health to expand access to cholesterol testing services in underserved regions. This partnership aims to deploy mobile testing units and telehealth services to reach remote areas, improving healthcare equity.
- April 2024: BioTech Innovations, a startup company, unveiled a novel biosensor-based cholesterol test kit designed for home use, providing quick and reliable results. This kit leverages smartphone integration for result interpretation and record-keeping, promoting proactive health management.
- March 2024: Researchers at Johns Hopkins University published a study on the development of a new optical biosensor technology for cholesterol testing, demonstrating high sensitivity and specificity. This technology promises to enhance the accuracy of cholesterol tests and is expected to be commercialized in the near future.
- February 2024: Quest Diagnostics launched a comprehensive cholesterol management platform that includes both testing devices and a digital health app. This platform allows users to monitor their cholesterol levels, receive personalized health recommendations, and connect with healthcare professionals for ongoing support.
- January 2024: Kaiser Permanente introduced a community health initiative focused on cholesterol awareness and testing. The program includes free cholesterol screening camps, educational workshops, and the distribution of home test kits to promote routine cholesterol monitoring.
Report Details
| Report Characteristics |
| Market Size (2024) |
USD 109.8 Bn |
| Forecast Value (2033) |
USD 247.5 Bn |
| CAGR (2024-2033) |
9.4% |
| Historical Data |
2018 – 2023 |
| The US Market Size (2024) |
USD 35.9 Bn |
| Forecast Data |
2025 – 2033 |
| Base Year |
2023 |
| Estimate Year |
2024 |
| Report Coverage |
Market Revenue Estimation, Market Dynamics, Competitive Landscape, Growth Factors and etc. |
| Segments Covered |
By Product Type (Test Strips, Test Kits, Test Meters, and Other Product Types), By Test Type (High-Density Lipoprotein (HDL) Cholesterol, Low-Density Lipoprotein (LDL) Cholesterol, Total Cholesterol Test, Triglycerides/VLDL Cholesterol Test, and Other Test Types), By Technology (Biosensors, Spectrometry, and Chromatography), By End User (Hospitals, Diagnostic Centers, and Others) |
| Regional Coverage |
North America – The US and Canada; Europe – Germany, The UK, France, Russia, Spain, Italy, Benelux, Nordic, & Rest of Europe; Asia- Pacific– China, Japan, South Korea, India, ANZ, ASEAN, Rest of APAC; Latin America – Brazil, Mexico, Argentina, Colombia, Rest of Latin America; Middle East & Africa – Saudi Arabia, UAE, South Africa, Turkey, Egypt, Israel, & Rest of MEA
|
| Prominent Players |
Abbott Laboratories, Sigma-Aldrich Corp., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Boston Heart Diagnostics Corporation, Eurofins Scientific, F. Hoffmann-La Roche Ltd., AccuTech LLC, Akers Biosciences Inc., Home Access Health Corporation, Laboratory Corporation of America Holdings, PTS Diagnostics, and Other Key Players |
| Purchase Options |
HVMN Inc., Thync Global Inc., Apple Inc., Fitbit Inc., TrackmyStack, OsteoStrong, The ODIN, Thriveport LLC, Muse, Moodmetric, and Other Key Players |